本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Fortress Biotech Inc.

3.59
-0.0100-0.28%
盘后3.53-0.0600-1.67%18:22 EDT
成交量:154.56万
成交额:525.91万
市值:1.07亿
市盈率:-1.63
高:3.60
开:3.58
低:3.26
收:3.60
52周最高:3.90
52周最低:1.33
股本:2,975.48万
流通股本:2,168.84万
量比:0.56
换手率:7.13%
股息:- -
股息率:- -
每股收益(TTM):-2.1959
每股收益(LYR):-2.6890
净资产收益率:-784.32%
总资产收益率:-40.94%
市净率:2.43
市盈率(LYR):-1.34

数据加载中...

2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/17

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/28

重要事件披露

Form 8-K - Current report
2024/03/22

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/27

重要事件披露

Form 8-K - Current report
2024/01/03

重要事件披露

Form 8-K - Current report
2024/01/03

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/21

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/21

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/15

重要事件披露

Form 8-K - Current report
2023/11/15

重要事件披露

Form 8-K - Current report
2023/10/26

SEC问询函

Form CORRESP - Correspondence
2023/10/26

重要事件披露

Form 8-K - Current report
2023/10/10

重要事件披露

Form 8-K - Current report
2023/09/30

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/09/30

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/09/26

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]